NORTH HAVEN, Conn.--(BUSINESS WIRE)--Covidien Ltd. (NYSE: COV, BSX: COV), a leading global provider of healthcare products, announced today that one of its subsidiaries has acquired Scandius Biomedical Inc., a developer of devices for sports-related surgeries. Financial terms were not disclosed.
